Colgate Palmolive Co - CL STOCK NEWS

Cresco Labs (CSE:CL) has received approval from the Arizona Department of Health Services to commence adult-use cannabis sales at its Sunnyside dispensary in Phoenix starting mid-February. Arizona is the 12th state to legalize such sales, following voter approval in November. The company highlights that Arizona represents a crucial market due to its robust medical cannabis program and consumer demand, with over 300,000 active medical patients. Cresco's strategic investment in Arizona aligns with its goal to expand its branded product offerings to a broader customer base.

Colgate-Palmolive Company (NYSE:CL) reported a strong fourth quarter in 2020, with net sales rising by 7.5% to $4,324 million and organic sales increasing 8.5%. GAAP EPS remained steady at $0.75, while Base Business EPS grew 5% to $0.77. The gross profit margin improved 100 basis points to 61.1%. Colgate's market shares in toothpaste and manual toothbrushes were 39.8% and 31.1%, respectively. Looking ahead, the company expects a 4% to 7% increase in net sales for 2021, with gross margin expansion and mid-single-digit EPS growth.

Cresco Labs (CSE:CL, OTCQX:CRLBF) has launched 1.0 g and 0.5 mg Live Cartridges from its High Supply line in California and Illinois. These products feature 100% cannabis oil enriched with live terpenes at competitive prices, aiming to attract both enthusiasts and value shoppers. The expansion continues Cresco's strategy of developing a diverse brand portfolio, enhancing its offerings in the cannabis sector. This initiative follows the recent introduction of Cresco’s 1.0 g liquid live resin vape cartridges, supporting solid growth in a highly competitive market.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has successfully closed its overnight marketed offering of subordinate voting shares at C$16.00 per share, raising approximately US$125 million. The offering included sales in Canada (excluding Québec) and a private placement in the U.S. for qualified institutional buyers. Proceeds will be utilized for organic and inorganic growth initiatives and general corporate purposes. The offering was led by ATB Capital Markets Inc. as the sole bookrunner, with A.G.P./Alliance Global Partners serving as a financial advisor in the U.S.

Colgate-Palmolive Company (NYSE:CL) will host a live webcast for its 2020 fourth quarter and year-end earnings conference call on January 29, 2021, at 8:30 a.m. ET. Chairman, President, and CEO Noel Wallace, along with Chief Investor Relations Officer John Faucher, will lead the call. Investors can access the live webcast on Colgate’s website, with a recorded version available later. The company focuses on various sectors including Oral Care and Personal Care, and is recognized for its sustainability initiatives, reaching over one billion children through its oral health program.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has appointed Ty Gent as the new Chief Operating Officer. Gent brings over 35 years of experience from the CPG industry, including roles at US Foods and PepsiCo, where he optimized supply chains and improved operational processes. His expertise will enhance Cresco's scalability and operational efficiency in the rapidly growing cannabis market. Concurrently, David Ellis transitions from COO to Regional President of Operations for Emerging Markets, focusing on replicating successful strategies in new states.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) reported that its employees contributed over 5,000 volunteer hours in 2020 through the 'Make a Difference' initiative. This initiative, started in June 2020, aimed to support communities amid social justice movements following incidents involving George Floyd and others. Volunteers worked across 28 cities in eight states, aiding over 50 organizations, packaging food, and addressing local needs. CEO Charlie Bachtell emphasized the company’s commitment to corporate social responsibility and community support.

Cresco Labs (CSE:CL, OTCQX:CRLBF) announced pricing for an overnight marketed offering of subordinate voting shares at C$16.00, totaling approximately US$125 million. The pricing reflects a 3.3% discount to the last close on January 14, 2021. All shares are anticipated to be purchased by seven institutional investors. The offering will take place across Canada, except Québec, and in the U.S. as a private placement. Proceeds will be used for growth opportunities and corporate purposes, with closing expected around January 21, 2021.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has announced an overnight marketed offering of subordinate voting shares across Canada (excluding Québec) and privately to qualified institutional buyers in the U.S. The final pricing and terms are yet to be determined, with an additional 15% available for agents to cover over-allotments. Proceeds from the offering will support organic and inorganic growth opportunities and general corporate purposes. The securities are not registered under U.S. laws, thus may not be sold in the U.S. without proper registration or exemption.